PPBT: Purple Biotech Ltd Sof marja

Purple Biotech Ltd (PPBT) tovar belgisi

Purple Biotech o'simtalar chidamliligiga qarshi kurashish uchun ilg'or antitelalarni ishlab chiqadi. Savdo rentabelligi koeffitsiyenti ushbu tendentsiyani aniq ko'rsatadi, bunda 0.00 ko'rsatkichi ushbu darajani belgilaydi. Biroq, mintaqaviy mojarolar ishlab chiqarish zavodlari va eksport uchun xavflarni yuzaga keltirmoqda. Shu bilan birga, intizomli Isroil menejmenti xarajatlarni muvaffaqiyatli optimallashtirib, biofarmatsevtika biznesining moliyaviy barqarorligini ta'minlamoqda.

purple-biotech.com (PPBT) - Sof marja 04.07.2022dan 19.11.2026gacha

Purple Biotech Corp (PPBT) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Purple Biotech
Purple Biotech Ltd yetakchi tovari

Sof foyda marjasi barcha xarajatlar chegirib tashlanganidan keyin tushumning yakuniy foydaga aylangan qismini o'lchaydi. Purple Biotech (PPBT) uchun, uning aktivlari kam bo'lgan modeli va autsorsing asosidagi testlari bilan, ushbu ko'rsatkich infratuzilma xarajatlarisiz patentlarni kengaytirish samaradorligini aks ettiradi. Konsolidatsiyalangan sof foyda marjasini tahlil qilish orqali investor intellektual mulkdan olinadigan real daromadni ko'rishi mumkin. Maksimal qiymatlar aktivning haddan tashqari qiziganini ko'rsatishi mumkin, ko'rsatkichning pasayishi esa chegirma bilan sotib olish imkoniyatini taqdim etadi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)